PCSK9 inhibition: the way forward in the treatment of dyslipidemia

por Stoekenbroek, Robert M., Kastelein, John JP, Huijgen, Roeland
Publicado en BMC Med (2015)

How common are foot problems among individuals with diabetes? Diabetic foot ulcers in the Dutch population

por Stoekenbroek, Robert M., Lokin, Joost L.C., Nielen, Mark M., Stroes, Erik S.G., Koelemay, Mark J.W.
Publicado en Diabetologia (2017)

Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study(1)

por Verbeek, Rutger, Boekholdt, S. Matthijs, Stoekenbroek, Robert M., Hovingh, G. Kees, Witztum, Joseph L., Wareham, Nicholas J., Sandhu, Manjinder S., Khaw, Kay-Tee, Tsimikas, Sotirios
Publicado en J Lipid Res (2016)

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial

por Ray, Kausik K., Stoekenbroek, Robert M., Kallend, David, Nishikido, Toshiyuki, Leiter, Lawrence A., Landmesser, Ulf, Wright, R. Scott, Wijngaard, Peter L. J., Kastelein, John J. P.
Publicado en JAMA Cardiol (2019)

Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study

por Bernelot Moens, Sophie J., Stoekenbroek, Robert M., van der Valk, Fleur M., Verweij, Simone L., Koelemay, Mark J. W., Verberne, Hein J., Nieuwdorp, Max, Stroes, Erik S. G.
Publicado en BMC Cardiovasc Disord (2016)